Ignite Creation Date:
2025-12-24 @ 1:40 PM
Ignite Modification Date:
2025-12-29 @ 8:39 PM
Study NCT ID:
NCT01838395
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2013-04-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients
Sponsor:
BioLineRx, Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
ACTUAL
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-20
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-14
First Submit QC Date:
None
Study First Post Date:
2013-04-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-16
Results First Submit QC Date:
None
Results First Post Date:
2024-09-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-20
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL